STUDY OF THE DEGREE OF DYSBIOSIS IN THE ORAL FLUID OF PATIENTS FOLLOWING SURGICAL TUMOUR REMOVAL AND CHEMOTHERAPY DURING THE APPLICATION OF A THERAPEUTIC AND PREVENTIVE COMPLEX

Authors:

Abstract:

The study aimed to evaluate the effect of a therapeutic and preventive complex on the degree of dysbiosis in the oral fluid of patients following surgical removal of head and neck tumours and chemotherapy. Thirty-five adults aged 25–55 years were examined: 10 healthy controls, 10 patients receiving standard oncological care, and 15 patients receiving standard care combined with the proposed complex. The degree of dysbiosis was calculated from the ratio of relative urease and lysozyme activities in oral fluid at baseline and after 1, 3, 6, and 12 months. At baseline, the indicator exceeded the reference value approximately 15-fold in both patient groups. Standard treatment produced only a partial and temporary reduction. In the main group, the degree of dysbiosis decreased 1.7-, 4.1-, 6.5-, and 9.3-fold after 1, 3, 6, and 12 months, respectively, approaching the physiological range. The proposed complex promoted sustained restoration of oral microbial homeostasis.

Keywords:

head and neck tumours oral dysbiosis oral fluid therapeutic and preventive complex

References:

1. Makarenko OA, Khromahina LM., Khodakov IV. Metody doslidzhennya stanu kyshkovyka ta kistok u laboratornykh shchuriv: dovidnyk. Odesa: Odeskyy natsionalnyy universytet im. I.I. Mechnykova, 2022. 81 p. [in Ukrainian].
2. Rohach IM, Keretsman AO, Sitkar AD. Pravylno vybranyy metod statystychnoho analizu – shlyakh do yakisnoyi interpretatsiyi danykh medychnykh doslidzhen. Naukovyy visnyk Uzhhorodskoho universytetu, seriya "Medytsyna". 2017;2(56):124–128. [in Ukrainian].
3. Almhöjd U, Fisic A, Cevik-Aras H, Tuomi L, Finizia C, Almståhl A. Explorative study of stimulated saliva proteome in head and neck cancer patients pre- and post-treatment. Heliyon. 2024;10(20):e39033. DOI:10.1016/j.heliyon.2024.e39033.
4. Belfiore E, Di Prima G, Angellotti G, Panzarella V, De Caro V. Plant-Derived Polyphenols to Prevent and Treat Oral Mucositis Induced by Chemo- and Radiotherapy in Head and Neck Cancers Management. Cancers (Basel). 2024 Jan 6;16(2):260. DOI: 10.3390/cancers16020260.
5. Dahlén G, Hassan H, Blomqvist S, Carlén A. Rapid urease test (RUT) for evaluation of urease activity in oral bacteria in vitro and in supragingival dental plaque ex vivo. BMC Oral Health. 2018 May 18;18(1):89. DOI: 10.1186/s12903-018-0541-3.
6. Dipalma G, Inchingolo AM, Latini G, Ferrante L, Nardelli P, Malcangi G, et al. The effectiveness of curcumin in treating oral mucositis related to radiation and chemotherapy: a systematic review. Antioxidants (Basel). 2024;13(10):1160. DOI:10.3390/antiox13101160.
7. Ferraboschi P, Ciceri S, Grisenti P. Applications of lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiotics (Basel). 2021;10(12):1534. DOI:10.3390/antibiotics10121534.
8. Fine DH, Schreiner H. Oral microbial interactions from an ecological perspective: a narrative review. Front Oral Health. 2023 Sep 13;4:1229118. DOI: 10.3389/froh.2023.1229118.
9. Gonzalez Agurto M, Olivares N, Canedo-Marroquin G, Espinoza D, Tortora SC. The Intersection of the Oral Microbiome and Salivary Metabolites in Head and Neck Cancer: From Diagnosis to Treatment. Cancers (Basel). 2024;16(20):3545. DOI: 10.3390/cancers16203545.
10. Hong BY, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66. DOI:10.1186/s40168-019-0679-5.
11. Kamstra JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU. Exercise therapy for trismus secondary to head and neck cancer: a systematic review. Head Neck. 2017 Nov;39(11):2352–2362. DOI: 10.1002/hed.24859.
12. Moutsopoulos NM, Konkel JE. Tissue-specific immunity at the oral mucosal barrier. Trends Immunol. 2018;39(4):276–287. DOI:10.1016/j.it.2017.08.005.
13. Peng TR, Tsai FP, Wu TW. Effects of various treatments for preventing oral mucositis in cancer patients: a network meta-analysis. PLoS One. 2022;17(12):e0278102. DOI:10.1371/journal.pone.0278102.
14. Şenel S. An overview of physical, microbiological and immune barriers of oral mucosa. Int J Mol Sci. 2021;22(15):7821. DOI:10.3390/ijms22157821.
15. Yang B, Li W, Shi J. Preventive effect of probiotics on oral mucositis induced by anticancer therapy: a systematic review and meta-analysis of randomized controlled trials. BMC Oral Health. 2024;24(1):1159. DOI:10.1186/s12903-024-04955-7.

Publication:

«World of Medicine and Biology» Vol. 22 No. 96 (2026) , с. 60-65
УДК [616-053.88+616-006.04]:616.31-08-039.71

DOI:

https://doi.org/10.26724/2079-8334-2026-2-96-60-65